Enhanced cancer risk among patients with bipolar disorder

Journal of Affective Disorders

Volumn 108, Issue 1-2, 2008, Pages 43-48

  BarChana, Micha ^a   Levav, Itzhak ^a   Lipshitz, Irena ^a   Pugachova, Inna ^a   Kohn, Robert ^b   Weizman, Abraham ^c,d   Grinshpoon, Alexander ^e  

^a MINISTRY OF HEALTH   (Israel)

^b BROWN UNIVERSITY   (United States)

^c GEHA MENTAL HEALTH CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e Technion Medical School   (Israel)

Author keywords

Bipolar disorder; Cancer; Epidemiology; Israel

Indexed keywords

ARTICLE; BIPOLAR DISORDER; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE;

AGE FACTORS; BIPOLAR DISORDER; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; ISRAEL; MALE; MEDICAL RECORD LINKAGE; NEOPLASMS; PATIENT ADMISSION; RISK; SEX FACTORS;

EID: 41249083126     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.09.003     Document Type: Article

References (39)

1. Carney C.P., and Jones L.S. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom. Med. 68 (2006) 684-691
2. Carney P.C., Woolson R.F., Jones L., Noyes R., and Doebbeling B.N. Occurrence of cancer among people with mental health claims in an insured population. Psychol. Med. 66 (2004) 735-743
3. Chuang D.M. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Ann. N.Y. Acad. Sci. 1053 (2005) 195-204
4. Cowey S., and Hardy R.W. The metabolic syndrome: a high-risk state for cancer?. Am. J. Pathol. 169 (2006) 1505-1522
5. Craddock N., O'Donovan M.C., and Owen M.J. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr. Bull. 32 (2006) 9-16
6. Cradock-O'Leary J., Young A.S., Yano E.M., Wang M., and Lee M.L. Use of general medical services by VA patients with psychiatric disorders. Psychiatr. Serv. 53 (2002) 874-878
7. Dalton S.O., Laursen T.L., and Mellemkjaer L. Risk of cancer in parents of patients with schizophrenia. Am. J. Psychiatry 161 (2004) 903-908
8. Fishler Y., Barchana M., and Tischler T. Cancer registry training program for health information management professionals in Israel. J. Reg. Management 29 (2002) 78-85
9. Goldacre M.J., Kurina L.M., and Wotton C.J. Schizophrenia and cancer: an epidemiological study. Br. J. Psychiatry 187 (2005) 334-338
10. Grinshpoon A., Barchana M., Ponizovsky A., Lipshitz I., Nahon D., Tal O., Weizman A., and Levav I. Cancer in schizophrenia: is the risk higher or lower?. Schizophr. Res. 73 (2005) 333-341
11. Høyer E.H., Mortensen P.B., and Olesen A.V. Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993. Br. J. Psychiatry 176 (2000) 76-82
12. Hrzenjak A., Moinfar F., Kremser M.L., Strohmeier B., Staber P.B., Zatloukal K., and Denk H. Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells. Mol. Cancer Ther. 5 (2006) 2203-2210
13. Israel Center for Disease Control. Trends in Morbidity and Mortality of Malignant Diseases in Israel, 1970-1995. Publication No.163 (1998), Israel Center for Disease Control, Jerusalem
14. Israel National Cancer Registry. Cancer in Israel - Annual Reports of the Israel National Cancer Registry, 1990, 1991, 1992, 1993, 1994, 1995, 1996, 1997, 1998, 1999, 2000. Ministry of Health, Jerusalem. (www.health.gov.il/icr). Accessed in December 2006.
15. Kilian R., Becker T., Kruger K., Schmid S., and Frasch K. Health behavior in psychiatric in-patients compared with a German general population sample. Acta Psychiatr. Scand. 114 (2006) 242-248
16. Krishnan K.R. Psychiatric and medical comorbidities of bipolar disorder. Psychosom. Med. 67 (2005) 1-8
17. Lai J.S., Zhao C., Warsh J.J., and Li P.P. Cytoprotection by lithium and valproate varies between cell types and cellular stresses. Eur. J. Pharmacol. 539 (2006) 18-26
18. Laursen T.M., Munk-Olsen T., Nordentoft M., and Mortensen P.B. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J. Clin. Psychiatry 68 (2007) 899-907
19. Lawrence D., Holman C.D., Jablensky A.V., Threlfall T.J., and Fuller S.A. Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatr. Scand. 101 (2000) 382-388
20. Levav I., and Grinshpoon A. Mental health services in Israel. Int. Psychiatry 4 (2004) 10-14
21. Levav I., Lipshitz I., Nobikov I., Kohn R., Bar-Chana M., Ponizovsky A., and Werner H. Cancer risk among parents and siblings of patients with schizophrenia. Br. J. Psychiatry 190 (2007) 156-161
22. Lichtenberg P., Kaplan Z., Grinshpoon A., Feldman D., and Nahon D. The goals and limitations of Israel's psychiatric case register. Psychiatr. Serv. 50 (1999) 1043-1048
23. Lichtermann D., Ekelund J., and Pukkala E. Incidence of cancer among patients with schizophrenia and their relatives. Arch. Gen. Psychiatry 27 (2004) 187-195
24. McIntyre R.S., Konarski J.Z., Wilkins K., Soczynska J.K., and Kennedy S.H. Obesity in bipolar disorder and major depressive disorder: results from a national community health survey on mental health and well-being. Can. J. Psychiatry 51 (2006) 274-280
25. Mental Health Services, Department of Information and Evaluation Ministry of Health Mental Health in Israel, 2004. Statistical Annual 2003. Ministry of Health, Jerusalem.
26. Newcomer J.W. Medical risk in patients with bipolar disorder and schizophrenia. J. Clin. Psychiatry 67 Suppl 9 (2006) 25-30
27. Noble W., Planel E., Zehr C., Olm V., Meyerson J., Suleman F., Gaynor K., Wang L., LaFrancois J., Feinstein B., Burns M., Krishnamurthy P., Wen Y., Bhat R., Lewis J., Dickson D., and Duff K. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc. Natl. Acad. Sci. 102 (2005) 6990-6995
28. Osborn D.P., Levy G., Nazareth I., Petersen I., Islam A., and King M.B. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch. Gen. Psychiatry 64 (2007) 242-249
29. Osby U., Brandt L., Correia N., Ekborn A., and Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch. Gen. Psychiatry 58 (2001) 844-850
30. Owen M.J., Craddock N., and Jablensky A. The genetic deconstruction of psychosis. Schizophr. Bull. 33 (2007) 905-911
31. In: Parkin D.M., Whelan S.L., and Ferlay J. (Eds). Cancer Incidence in Five Continents vol. VIII (2002), International Agency for Research on Cancer, Lyon
32. Rabinowitz J., Slyuzberg M., and Ristner M. Changes in diagnosis in a 9-year national longitudinal sample. Compr. Psychiatry 35 (2000) 361-365
33. Senatorov V.V., Ren M., Kanai H., Wei H., and Chuang D.M. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease. Mol. Psychiatry 9 (2004) 371-385
34. Taylor V., and MacQueen G. Associations between bipolar disorder and metabolic syndrome: a review. J. Clin. Psychiatry 67 (2006) 1034-1041
35. van Vliet J., Oates N.A., and Whitelaw E. Epigenetic mechanisms in the context of complex diseases. Cell Mol. Life Sci. 64 (2007) 1531-1538
36. Waxmonsky J.A., Thomas M.R., Miklowitz D.J., Allen M.H., Wisniewski S.R., Zhang H., Ostacher M.J., and Fossey M.D. Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program. Gen. Hosp. 27 (2005) 321-328
37. Weeke A., and Vaeth M. Excess mortality of bipolar disorders and unipolar manic-depressive patients. J. Affective Disord. 11 (1986) 227-234
38. Weiser M., Kanyas K., and Malaspina D. Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L. Compr. Psychiatry 46 (2005) 38-42
39. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678